|
2000 Conference Publication Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation modelJonsson, J. R., Ando, Y., Kelemen, L., Clouston, A. D. and Powell, E. (2000). Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model. American Association for Study of Liver Disease, Dallas, U.S.A., 27-31 Oct, 2000. Orlando, U.S.A.: WB Saunders. |
|
2000 Conference Publication The role of cytokine gene polymorphisms in renal impairment after liver transplantationJonsson, Julie R., Hong, Cui, Isbel, Nicky, Hawley, Carmel, Butler, Maree, Purdie, David M., Pandeya, Nirmala, Balderson, Glenda A., Clouston, Andrew D., Edwards-Smith, C., Lynch, Stephen V. and Powell, Elizabeth E. (2000). The role of cytokine gene polymorphisms in renal impairment after liver transplantation. American Association for Study of Liver Disease, Dallas, U.S.A., 27-31 October, 2000. Hoboken, NJ: Wiley Interscience. |
|
2000 Conference Publication The role of cytokine gene polymorphisms in acute rejection after liver transplantationHong, C., Powell, E. E., Balderson, G. A., Clouston, A. D., Purdie, D. M., Pandeya, N., Edwards-Smith, C. J., Stuart, K. A., Crawford, D. H., Fawcett, J., Lynch, S. V. and Jonsson, J. R. (2000). The role of cytokine gene polymorphisms in acute rejection after liver transplantation. -, -, -. PHILADELPHIA: W B SAUNDERS CO. |
|
2000 Conference Publication The role of cytokine gene polymorphisms in acute rejection after liver transplantationJonsson, J. R., Cui, H., Powell, E., Pandeyer, N., Balderson, G. A., Clouston, A. D., Edwards-Smith, C., Stuart, K. A., Crawford, D. H., Fawcett, J., Lynch, S. V. and Purdie, D. M. (2000). The role of cytokine gene polymorphisms in acute rejection after liver transplantation. Australian Gastroenterology Week 2000, Hobart, Australia, 18-21 October, 2000. Melbourne: Blackwell Scientific. |
|
2000 Conference Publication The role of cytokine gene polymorphisms in renal impairment after liver transplantationJonsson, J. R., Hong, C., Isbel, N., Hawley, C., Butler, M., Purdie, D. M., Pandeva, N., Balderson, G. A., Clouston, A. D., Edwards-Smith, C. J., Lynch, S. V. and Powell, E. E. (2000). The role of cytokine gene polymorphisms in renal impairment after liver transplantation. -, -, -. PHILADELPHIA: W B SAUNDERS CO. |
|
1999 Conference Publication The clinico-pathological features of hepatocellular carcinoma occurring in non-cirrhotic patientsHiggins, C, Clouston, A and Strong, R (1999). The clinico-pathological features of hepatocellular carcinoma occurring in non-cirrhotic patients. PHILADELPHIA: W B SAUNDERS CO. |
|
1999 Conference Publication Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liverHiggins, C., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liver. American Association for the Study of Liver Diseases, Dallas, USA, 5-9 Nov, 1999. Baltimore: Williams & Wilkins. |
|
1999 Conference Publication Clinicopathological analysis of hepatocellular carcinoma occuring in non-cirrhotic patientsHiggins, C. M., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). Clinicopathological analysis of hepatocellular carcinoma occuring in non-cirrhotic patients. Australian Gastroenterology Week 1999, Brisbane Convention Centre, 4-8 October, 1999. Carlton South, Vic.: Blackwell Publishing Asia. |
|
1999 Conference Publication The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patientsHiggins, C., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patients. Australian Gastroenterology Week 1999, Brisbane, 4-8 Oct, 1999. Carlton, Vic: Blackwell Science. |
|
1999 Conference Publication Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October,1999. Carlton, Vic: Blackwell Science Asia. |
|
1999 Conference Publication Fibrosis in chronic rejection of liver allografts occurs in several pathwaysNakazawa, Y., Walker, N. I., Kerlin, P., Strong, R. W., Lynch, S. V. and Clouston, A. D. (1999). Fibrosis in chronic rejection of liver allografts occurs in several pathways. Aust. Academy of Science, Canberra, 14-16 Apr, 1999. Carlton, Vic.: Blackwell Science. |
|
1999 Conference Publication Iron overload in end-stage liver disease: Relationship to disease severity and post-transplant outcomeStuart, K. A., Fletcher, L. M., Clouston, A., Purdie, D. M., Lynch, S. V., Kerlin, P. and Crawford, D. H. (1999). Iron overload in end-stage liver disease: Relationship to disease severity and post-transplant outcome. Australian Gastroenterology Week 1999, Brisbane, 4-8 October, 1999. Carlton, Vic: Blackwell Science. |
|
1999 Conference Publication Venous sclerosis and fibrosis in chronic rejection of liver allograftsNakazawa, Y., Walker, N. I., Lynch, S. V. and Clouston, A. D. (1999). Venous sclerosis and fibrosis in chronic rejection of liver allografts. 5th Banff Consensus Conference of Allograft Pathology, Banff Springs, Canada, 7-12 June, 1999. Internet: Univ. of Pitsburgh Medical Cen.. |
|
1999 Conference Publication Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.Ramm, G.A., Murphy, T.L., Fanning, P.A., Clouston, A.D., Anderson, G.J. and Crawford, D.H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.. 50th Annual Meeting American Association for the Study of Liver Disease, Dallas, TX, United States, 5-9 November 1999. Hoboken, NJ, United States: John Wiley & Sons. |
|
1999 Conference Publication Role of donor leukocyte chimerism in establishing the aetiology of neutropenia following liver transplantationJonsson, J. R., Gill, D., Hogan, P., Clouston, A. D., Edwards-Smith, C. and Griffin, A. (1999). Role of donor leukocyte chimerism in establishing the aetiology of neutropenia following liver transplantation. -, Canberra, 14th- 16th June, 1999. |
|
1999 Conference Publication Quantification of donor leucocytes in pre-transplant liver biopsies: No correlation with graft outcomeClouston, A., Powell, E., Balderson, G.A., Edwards-Smith, C., Hogan, P. and Lynch, S. V. (1999). Quantification of donor leucocytes in pre-transplant liver biopsies: No correlation with graft outcome. Transplantation Society of Australia and New Zealand 17th Annual Scientific Meeting, Aust. Academy of Science, Canberra, 14-16 Apr, 1999. Canberra: The Transplantation Society of Aust. and New Zealand. |
|
1999 Conference Publication Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. Bioiron'99, Sorrento Palace, Sorrento - Naples, Italy, 23 - 28 May 1999. Italy: SGC. |
|
1999 Conference Publication The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion modelSaxton, N., Barclay, J., Clouston, A. D. and Fawcett, J. (1999). The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion model. Transplantation Society of Australia/New Zealand Annual Scientific Meeting, Canberra, 14-16 Jun, 1999. Asia: Blackwell Science. |
|
1999 Conference Publication Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. American Assoc. for the Study of Liver Diseases 50th Annual Meeting, Dallas, Texas, USA, 5 - 9 Nov, 1999. USA: W B Saunders Co.. |
|
1999 Conference Publication Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosisNakazawa, Y., Walker, N. I., Kerlin, P., Strong, R. W., Lynch, S. V. and Clouston, A. D. (1999). Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosis. As above, Aust. Academy of Science, Canberra, 14-16 Apr, 1999. Carlton, Vic.: Blackwell Science Asia. |
